News | January 18, 2024
Torque Pharma reinvents healthcare dynamics with 'Better Together'
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
The closing of the Block Acquisition is now expected to be completed by Q3 2025
Subscribe To Our Newsletter & Stay Updated
